Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies |
Heterozygous or Homozygous Familial Hypercholesterolemia | Phase 3 | Spain Netherlands Lebanon South Africa United States Brazil Germany Switzerland Turkey Israel Russian Federation Slovenia United Kingdom Italy Norway Hungary Canada Taiwan France View All |
Long-term Extension Study of Ligelizumab in Food Allergy |
Food Allergy | Phase 3 | United States France Spain Germany Italy View All |
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up |
Chronic Spontaneous Urticaria | Phase 3 | United States Turkey Thailand Spain Italy China Germany Argentina Netherlands Hong Kong Japan Malaysia Poland Canada Chile Singapore View All |
Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy |
Macular Polypoidal Choroidal Vasculopathy (PCV) | Phase 3 | Korea, Republic of |
A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer |
Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase 2 | China |
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) |
Primary Immune Thrombocytopenia (ITP) | Phase 3 | United States Turkey Thailand Spain China United Kingdom Italy Czech Republic Belgium Romania Hungary Argentina France Australia Japan Mexico Germany Norway Vietnam Hong Kong Austria Malaysia India Bulgaria Singapore View All |
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids |
Primary Immune Thrombocytopenia | Phase 3 | United States Turkey Japan Thailand Spain China Italy Czech Republic Romania Hungary Argentina India Australia Germany Norway Korea, Republic of Malaysia Taiwan Belgium Austria United Kingdom Philippines Singapore Netherlands View All |
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia |
Warm Autoimmune Hemolytic Anemia (wAIHA) | Phase 3 | United States Israel Japan Italy Thailand Spain France Romania Argentina Australia China Hungary Germany Malaysia United Kingdom India Singapore Taiwan View All |
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis |
Aortic Stenosis | Phase 2 | Israel United Kingdom |
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) |
Systemic Lupus Erythematosus | Phase 3 | United States Turkey Spain Thailand China Brazil Portugal Slovakia Czech Republic Poland South Africa Japan Guatemala Hungary Israel Bulgaria Canada Singapore View All |